PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Certara USA, Inc, Princeton, NJ, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/bcp.15009
?:doi
?:hasPublicationType
?:journal
  • British journal of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34318516
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.543
?:rankingScore_hIndex
  • 126
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 acute respiratory distress syndrome: A simulation study of the effects of combination therapy with tocilizumab and siltuximab.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all